68Ga-FAPI-04 PET/CT在人体动脉壁成纤维细胞激活蛋白显像中的可行性
本研究回顾性分析41例因非心血管指征接受68Ga-FAPI-04 PET/CT的患者,评估大动脉壁摄取与钙化程度及心血管危险因素的相关性。结果显示动脉壁TBR与钙化程度呈负相关(r=-0.27,P<0.01),高危患者平均TBR高于低危患者(2.2±0.3 vs 1.8±0.3,P<0.01)。结论认为68Ga-FAPI-04 PET/CT可能具有动脉壁成纤维细胞激活显像的潜力。
要点
- 68Ga-FAPI-04 PET/CT可显示动脉壁局灶性摄取,41例患者共1177个动脉节段检出摄取或钙化。
- 动脉壁TBR与钙化程度(Hounsfield单位)呈负相关(r=-0.27,P<0.01)。
- 高危患者平均TBR高于低危患者(2.2±0.3 vs 1.8±0.3,P<0.01)。
核心结论
- 68Ga-FAPI-04 PET/CT可能具有对动脉壁成纤维细胞激活进行显像的潜力。
研究设计与样本
- 回顾性分析41例因非心血管指征接受68Ga-FAPI-04 PET/CT的患者。
主要发现
- 41例患者共1177个动脉节段检出68Ga-FAPI-04局灶性摄取或钙化。
- 动脉壁TBR与钙化程度(Hounsfield单位)呈负相关(r=-0.27,P<0.01)。
- 高危患者平均TBR高于低危患者(2.2±0.3 vs 1.8±0.3,P<0.01)。
- 颈动脉斑块免疫组化显示薄纤维帽中FAP表达显著,厚纤维帽中FAP表达中等。
临床怎么用
- 在非心血管指征的68Ga-FAPI-04 PET/CT中可偶然评估动脉壁FAP摄取,辅助判断斑块成纤维细胞激活状态。
局限性
- 回顾性设计,样本量有限(41例),且患者为非心血管指征人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increased expression of fibroblast-activating protein (FAP) in fibrous caps may contribute to progression of atherosclerotic plaques. Methods: Forty-one patients who underwent 68Ga-conjugated quinoline-based FAP inhibitor (68Ga-FAPI-04) PET/CT for noncardiovascular indications were retrospectively analyzed. Correlations were assessed between the uptake of 68Ga-FAPI-04 in large arterial walls (SUVmax and target-to-background ratio, TBR) and degree of calcification and cardiovascular risk factors. Results: Focal arterial uptake of 68Ga-FAPI-04 or calcification was detected in 1,177 arterial segments in all 41 patients. TBR was negatively correlated with the degree of calcification (Hounsfield units) (r = -0.27, P < 0.01). Mean TBR in higher-risk patients was greater than in lower-risk patients (2.2 ± 0.3 vs. 1.8 ± 0.3, P < 0.01). Immunohistochemical labeling of carotid plaques exhibited prominent FAP expression in a thin fibrous cap and moderate FAP expression in a thick cap. Conclusion:68Ga-FAPI-04 PET/CT might have potential for imaging fibroblastic activation in the arterial wall.
引用
- Wu M, Ning J, Li J, et al. Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls. J Nucl Med. 2021. PMID: 34531265. doi:10.2967/jnumed.121.262863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。